Table 1 FDCS in the pancreatic have been previously reported cases in addition to present case
Publication year | Age/sex | Country | Location | Size (cm) | Immunohistochemistry | Treatment | Follow-up/outcome | Metastasis |
|---|---|---|---|---|---|---|---|---|
1995 [5] | 63/M | UK | Head | 15 × 11.5 × 9.5 | CD21, CD35 | Surgery | 4 months/NR | None |
2006 [6] | 64/M | China | Head | 10.5 × 9.0 × 6.5 | CD21, CD23, CD35 | Surgery | 18 months/R | Liver |
2007 [7] | 56/M | USA | - | 2 | CD21, CD23 | Surgery XRT + CHOP | 7 months/R | LN |
2016 [8] | 67/F | China | Tail | 4 × 4 × 4.5 | CD21, CD23 | Surgery | - | None |
2019 [4] | 49/F | China | Tail | 4 × 5 | CD21, CD23, CD35 | Surgery | 15 days/death | None |
2019 [9] | 70/F | USA | Tail | 8.5 × 5.5 × 3.2 | CD21, CD23, CD35 | Surgery | 3 months/R | Spleen |
2022 [10] | 30/M | China | Head | 10 × 9 × 8 | CD21, CD35 | Surgery | 3 months/R | Liver, LN |
2023 | 67/M | China | Tail | 6 × 5 | CD21, CD35 | Surgery | 8 months/R | Liver, LN |